# Comparing CHG I.V. Securement Dressing With Transparent Dressing for Evaluation of Antimicrobial Efficacy

> **NCT04906512** · NA · TERMINATED · sponsor: **Solventum US LLC** · enrollment: 123 (actual)

## Conditions studied

- Central Venous Catheter Exit Site Infection
- Catheter-Related Infections

## Interventions

- **DEVICE:** 3M™ Tegaderm™ CHG I.V. Securement Dressing
- **DEVICE:** 3M™ Tegaderm™ Transparent Film Dressing 1626W

## Key facts

- **NCT ID:** NCT04906512
- **Lead sponsor:** Solventum US LLC
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-05-14
- **Primary completion:** 2022-03-31
- **Final completion:** 2022-03-31
- **Target enrollment:** 123 (ACTUAL)
- **Why stopped:** The decision to terminate this clinical study was made as a cost control measure.
- **Last updated:** 2024-10-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04906512

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04906512, "Comparing CHG I.V. Securement Dressing With Transparent Dressing for Evaluation of Antimicrobial Efficacy". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04906512. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*